GenSpera, Inc. announced that Santosh Kesari, MD, PhD, a board-certified neurologist and neuro-oncologist and a recognized leader in these fields, has joined the company's Scientific Advisory Board. Dr. Kesari is Chair of the Department of Translational Neuro-Oncology and Neurotherapeutics at the John Wayne Cancer Institute and Director of Neuro-Oncology at Providence Saint John's Health Center.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% |
|
0.00% | -98.04% |
1st Jan change | Capi. | |
---|---|---|
-98.04% | 3.21T | |
+16.45% | 12TCr | |
+21.96% | 11TCr | |
+23.73% | 2.59TCr | |
-20.05% | 2.09TCr | |
-16.28% | 1.68TCr | |
-16.52% | 1.65TCr | |
-44.35% | 1.56TCr | |
+63.91% | 1.55TCr | |
+2.52% | 1.34TCr |
- Stock Market
- Equities
- RBSH Stock
- News Rebus Holdings, Inc.
- Santosh Kesari Joins GenSpera, Inc.'s Scientific Advisory Board